SVB Leerink analyst Joseph Schwartz maintains Solid Biosciences (NASDAQ:SLDB) with a Market Perform and raises the price target from $1 to $6.
Morgan Stanley Maintains Equal-Weight on Charter Communications, Lowers Price Target to $420
Morgan Stanley analyst Benjamin Swinburne maintains Charter Communications (NASDAQ:CHTR) with a Equal-Weight and lowers the price target from $550 to $420.